| EPA0073 | Developing triplex forming oligonucleotides as a ‘block and lock’ strategy for an HIV cure | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0074 | Assessment of monovalent and bivalent SMAC mimetics to both shock and kill the HIV reservoir | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0075 | Synergistic effects of romidepsin with PI3K inhibitors in reducing the pool of HIV latently infected cells ex vivo | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0076 | Tat diversity in intact versus defective proviral HIV-1 DNA genomes across viral subtypes | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0077 | Upregulation of TCF1 improves the efficiency of latency reversing agents for HIV-1 transcriptional reactivation | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0078 | Genetic diversity of HIV-1 long terminal repeat in proviral populations during long-term antiretroviral therapy | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0079 | Delineating the role of transcription factor BRD9 in HIV-1 latency reactivation | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0080 | Effect of combination latency reversing agents and bNAb in SHIV-infected rhesus macaques on antiretroviral therapy | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0081 | Transient upregulation of CD4 increases permissibility of Vδ1 T cells to HIV-1 infection | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0082 | Molecular deep sequencing analysis of rebound viruses from antiretroviral drug and CRISPR-treated HIV-infected humanized mice | E-poster | Understanding and targeting persistent HIV reservoirs |